ANDA 76754, held by The J Molner. Ciprofloxacin Hydrochloride.
As of Nov 15, 2026, ANDA 76754 (Ciprofloxacin Hydrochloride), held by The J Molner, was first approved by FDA on Jun 9, 2004, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 9, 2004 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ciprofloxacin HydrochlorideEQ 0.3% BASE ยท solution/drops;ophthalmic | Ciprofloxacin Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
